Current Research into Cures for Type-1 Diabetes

Rituximab is FDA-approved to treat several autoimmune diseases, including Rheumatoid Arthritis (RA).  About 10 years ago there were a coupl...

Data from 2 Year Follow up of R ituximab (anti-CD20) Rituximab works by suppressing a specific cell in the immune system, which is involve...

I feel like I'm about two month behind, but this will get me closer to current news. Kamada Reports Early Results from A Phase-I Tria...

More News on Rituximab Background on the drug: Rituximab targets the CD20 part of the immune system's B cells (different from the pan...

Exsulin's Phase-II Trial is Data Complete  The exact update I got on the Exsulin phase-II trial is this: "We have finished recrui...

Canakinumab Completes Enrollment Canakinumab is a monoclonal antibody, which is designed to lower inflammation.  It targets IL-1β (interl...

Here are various news items on possible cures for type-1 diabetes which are in human trials, and related items: Diamyd Completes Enrollmen...

Pescovitz (and team from TrialNet) have finished a phase-II human trial of Rituximab, and the results have been accepted for publication at ...